(Q37681724)

22 August 2017

Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis (English)

1 reference

22 August 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Luke J Dowman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Angel Pang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Roger G Linington

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Susan A. Charman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Christopher G. Dowson

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

David I Roper

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

8

Weng Ruh Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Anh T Tran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Venugopal Pujari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Trent Conroy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Andrew M Giltrap

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Sebabrata Mahapatra

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Jessica Saunders

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Timothy D H Bugg

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Julie Tod

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Dean C Crick

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Warwick J Britton

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Richard J Payne

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Nicholas P West

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

English

0 references

publication date

1 March 2017

1 reference

22 August 2017

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

14414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

14 June 2020

copyright license

start time

1 March 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageQuant

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC5337940/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Structural insights into inhibition of lipid I production in bacterial cell wall synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Natural products as sources of new drugs over the 30 years from 1981 to 2010

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Natural products as sources of new drugs over the last 25 years

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

A solid-phase approach to analogues of the antibiotic mureidomycin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Antibacterial Nucleoside Natural Products Inhibiting Phospho-MurNAc-Pentapeptide Translocase; Chemistry and Structure-Activity Relationship

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Lead structures for new antibacterials: stereocontrolled synthesis of a bioactive muraymycin analogue.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Advances in the development of new tuberculosis drugs and treatment regimens

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Phospho-N-acetyl-muramyl-pentapeptide translocase from Escherichia coli: catalytic role of conserved aspartic acid residues

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Selective inhibition of the bacterial translocase reaction in peptidoglycan synthesis by mureidomycins

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Mechanism of action of the uridyl peptide antibiotics: an unexpected link to a protein-protein interaction site in translocase MraY.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Biogenesis of the unique 4',5'-dehydronucleoside of the uridyl peptide antibiotic pacidamycin.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Gene expression enabling synthetic diversification of natural products: chemogenetic generation of pacidamycin analogs

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Pacidamycin biosynthesis: identification and heterologous expression of the first uridyl peptide antibiotic gene cluster

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

New pacidamycins biosynthetically: probing N- and C-terminal substrate specificity

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Two novel nucleosidyl-peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

New pacidamycin antibiotics through precursor-directed biosynthesis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Sansanmycins B and C, new components of sansanmycins.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Characterization of tRNA-dependent peptide bond formation by MurM in the synthesis of Streptococcus pneumoniae peptidoglycan

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Synthesis and activity of 5'-uridinyl dipeptide analogues mimicking the amino terminal peptide chain of nucleoside antibiotic mureidomycin A.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Stereochemical elucidation and total synthesis of dihydropacidamycin D, a semisynthetic pacidamycin

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5337940

Total Synthesis of (−)-Caprazamycin A

1 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

Liposidomycins: novel nucleoside antibiotics which inhibit bacterial peptidoglycan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

The structure of a new nucleoside antibiotic, capuramycin

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

A New Nucleosidyl-peptide Antibiotic, Sansanmycin

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

NRPS Substrate Promiscuity Leads to More Potent Antitubercular Sansanmycin Analogues

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

Total synthesis and biological evaluation of pacidamycin D and its 3'-hydroxy analogue

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

Synthesis of pacidamycin analogues via an Ugi-multicomponent reaction

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

Carbacaprazamycins: Chemically Stable Analogues of the Caprazamycin Nucleoside Antibiotics

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS14414

7 January 2021

Identifiers

DOI

10.1038/NCOMMS14414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

14 June 2020

ADS bibcode

2017NatCo...814414T

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28248311%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

PubMed publication ID

28248311

1 reference